554 related articles for article (PubMed ID: 35354425)
1. Demystifying mRNA vaccines: an emerging platform at the forefront of cryptic diseases.
Rouf NZ; Biswas S; Tarannum N; Oishee LM; Muna MM
RNA Biol; 2022; 19(1):386-410. PubMed ID: 35354425
[TBL] [Abstract][Full Text] [Related]
2. Prospects and Challenges in Developing mRNA Vaccines for Infectious Diseases and Oncogenic Viruses.
Kutikuppala LVS; Kourampi I; Kanagala RSD; Bhattacharjee P; Boppana SH
Med Sci (Basel); 2024 May; 12(2):. PubMed ID: 38804384
[TBL] [Abstract][Full Text] [Related]
3. Production and Evaluation of Nucleoside-Modified mRNA Vaccines for Infectious Diseases.
Vadovics M; Muramatsu H; Sárközy A; Pardi N
Methods Mol Biol; 2024; 2786():167-181. PubMed ID: 38814394
[TBL] [Abstract][Full Text] [Related]
4. Recent Advances in the Molecular Design and Delivery Technology of mRNA for Vaccination Against Infectious Diseases.
Yang L; Tang L; Zhang M; Liu C
Front Immunol; 2022; 13():896958. PubMed ID: 35928814
[TBL] [Abstract][Full Text] [Related]
5. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.
Amanpour S
Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952
[TBL] [Abstract][Full Text] [Related]
6. mRNA vaccines for infectious diseases: principles, delivery and clinical translation.
Chaudhary N; Weissman D; Whitehead KA
Nat Rev Drug Discov; 2021 Nov; 20(11):817-838. PubMed ID: 34433919
[TBL] [Abstract][Full Text] [Related]
7. Advances in mRNA vaccines.
Li M; Wang Z; Xie C; Xia X
Int Rev Cell Mol Biol; 2022; 372():295-316. PubMed ID: 36064266
[TBL] [Abstract][Full Text] [Related]
8. COVID-19 mRNA vaccines: Platforms and current developments.
Szabó GT; Mahiny AJ; Vlatkovic I
Mol Ther; 2022 May; 30(5):1850-1868. PubMed ID: 35189345
[TBL] [Abstract][Full Text] [Related]
9. mRNA vaccines: the most recent clinical applications of synthetic mRNA.
Kwon S; Kwon M; Im S; Lee K; Lee H
Arch Pharm Res; 2022 Apr; 45(4):245-262. PubMed ID: 35426547
[TBL] [Abstract][Full Text] [Related]
10. Current Developments and Challenges of mRNA Vaccines.
Chen J; Chen J; Xu Q
Annu Rev Biomed Eng; 2022 Jun; 24():85-109. PubMed ID: 35231177
[TBL] [Abstract][Full Text] [Related]
11. mRNA Vaccines in the COVID-19 Pandemic and Beyond.
Hogan MJ; Pardi N
Annu Rev Med; 2022 Jan; 73():17-39. PubMed ID: 34669432
[TBL] [Abstract][Full Text] [Related]
12. mRNA vaccines for COVID-19 and diverse diseases.
Hussain A; Yang H; Zhang M; Liu Q; Alotaibi G; Irfan M; He H; Chang J; Liang XJ; Weng Y; Huang Y
J Control Release; 2022 May; 345():314-333. PubMed ID: 35331783
[TBL] [Abstract][Full Text] [Related]
13. The Current Landscape of mRNA Vaccines Against Viruses and Cancer-A Mini Review.
Ladak RJ; He AJ; Huang YH; Ding Y
Front Immunol; 2022; 13():885371. PubMed ID: 35603213
[TBL] [Abstract][Full Text] [Related]
14. The mRNA Vaccine Revolution: COVID-19 Has Launched the Future of Vaccinology.
Ye Z; Harmon J; Ni W; Li Y; Wich D; Xu Q
ACS Nano; 2023 Aug; 17(16):15231-15253. PubMed ID: 37535899
[TBL] [Abstract][Full Text] [Related]
15. Knife's edge: Balancing immunogenicity and reactogenicity in mRNA vaccines.
Lee J; Woodruff MC; Kim EH; Nam JH
Exp Mol Med; 2023 Jul; 55(7):1305-1313. PubMed ID: 37430088
[TBL] [Abstract][Full Text] [Related]
16. Clinical Development of mRNA Vaccines: Challenges and Opportunities.
August A; Brito L; Paris R; Zaks T
Curr Top Microbiol Immunol; 2022; 440():167-186. PubMed ID: 35906319
[TBL] [Abstract][Full Text] [Related]
17. Messenger RNA vaccines for cancer immunotherapy: progress promotes promise.
Huff AL; Jaffee EM; Zaidi N
J Clin Invest; 2022 Mar; 132(6):. PubMed ID: 35289317
[TBL] [Abstract][Full Text] [Related]
18. mRNA vaccine-a desirable therapeutic strategy for surmounting COVID-19 pandemic.
Chen P; Shi X; He W; Zhong G; Tang Y; Wang H; Zhang P
Hum Vaccin Immunother; 2022 Dec; 18(1):2040330. PubMed ID: 35321627
[TBL] [Abstract][Full Text] [Related]
19. mRNA Vaccines: The Dawn of a New Era of Cancer Immunotherapy.
Deng Z; Tian Y; Song J; An G; Yang P
Front Immunol; 2022; 13():887125. PubMed ID: 35720301
[TBL] [Abstract][Full Text] [Related]
20. Developing mRNA for Therapy.
Karikó K
Keio J Med; 2022; 71(1):31. PubMed ID: 35342149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]